ScholarWorks@Gyeongsang National University

Browsing by Lee, Ho SupAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 15 of 15

SCIESCOPUS
A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)

Jung, Sung-Hoon; Kim, Dajung; Lee, Je-Jung; Kim, Kihyun; Min, Chang-Ki; Lee, Jae Hoon; Lee, Won Sik; Lee, Ji Hyun; Lee, Gyeong Won; Kim, Min Kyoung, et al.

ArticleIssue Date2025CitationBritish Journal of HaematologyPublisherBlackwell Publishing Inc.
SCIESCOPUS
A Phase II Clinical Study for Evaluating the Efficacy and Safety of Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone in Transplantation-Eligible Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM2101)

Yoon, Sang Eun; Jung, Sung-Hoon; Lee, Gyeong Won; Min, Chang-Ki; Byun, Ja Min; Kwak, Jae-Yong; Lee, Myung-Won; Lee, Ho Sup; Kim, Seok Jin; Kim, Kihyun

ArticleIssue Date2024CitationBLOOD, v.144, pp 7045 - 7046PublisherELSEVIER
SCISCIESCOPUS
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study

Lee, Je-Hwan; Kim, Yoo-Jin; Sohn, Sang Kyun; Yoon, Sung-Soo; Kim, Hawk; Cheong, June-Won; Lee, Won-Sik; Lee, Gyeong-Won; Lim, Sung-Nam; Kim, Min Kyoung, et al.

ArticleIssue Date2017CitationLEUKEMIA RESEARCH, v.60, pp 135 - 144PublisherPERGAMON-ELSEVIER SCIENCE LTD
SCIESCOPUSKCI
Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Studyopen access

Shin, Seong Hoon; Lee, Ho Sup; Kim, Yang Soo; Choi, Young Jin; Kim, Sung Hyun; Kwon, Hyuk Chan; Oh, Sung Yong; Kang, Jung Hun; Sohn, Chang Hak; Lee, Sang Min, et al.

ArticleIssue Date2014CitationCANCER RESEARCH AND TREATMENT, v.46, no.4, pp 331 - 338PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome

Park, Sungwoo; Baek, Dong Won; Sohn, Sang Kyun; Ahn, Jae-Sook; Kim, Hyeoung-Joon; Shin, Ho Fin; Chung, Joo Seop; Lee, Sang Min; Lee, Won Sik; Lim, Sung Nam, et al.

ArticleIssue Date2019CitationCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.19, no.7, pp E367 - E373PublisherCIG MEDIA GROUP, LP
SCIESCOPUS
Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma

Park, Sungwoo; Jo, Jae-Cheol; Do, Young Rok; Yang, Deok-Hwan; Lim, Sung-Nam; Lee, Won-Sik; Kim, Won Seog; Lee, Ho Sup; Hong, Dae-Sik; Kim, Hyo Jung, et al.

ArticleIssue Date2019CitationCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.19, no.3, pp 149 - 156PublisherCIG MEDIA GROUP, LP
SCIESCOPUS
Multicenter Prospective Phase II Study of Rituximab Combined, Bortezomib, Lenalidomide, Dexamethasone Followed By Lenalidomide Maintenance (R-VRD) in Patients with Waldenstrom's Macroglobulinemia (KMM1803)open access

Lee, Ho Sup; Kim, Dajung; Jung, Sung-Hoon; Lee, Je-Jung; Kim, Kihyun; Min, Chang-Ki; Lee, Jae Hoon; Lee, Won-Sik; Lee, JiHyun; Lee, Gyeong Won, et al.

ArticleIssue Date2023CitationBlood, v.142PublisherAmerican Society of Hematology
SCIESCOPUS
Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma studyopen access

Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Lee, Suee; Lee, Dae Ho; Won, Jong-Ho; Hwang, In Gyu; Kim, Min Kyoung; Lee, Soon Il, et al.

ArticleIssue Date2010CitationINTERNATIONAL JOURNAL OF HEMATOLOGY, v.92, no.3, pp 510 - 517PublisherSPRINGER JAPAN KK
SCISCIESCOPUS
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)open access

Jo, Jae-Cheol; Lee, Ho Sup; Suh, Cheolwon; Kang, Hye Jin; Kim, Won Seog; Eom, HyeonSeok; Kim, Inho; Shin, Ho-Jin; Park, Yong; Lee, Won Sik, et al.

ArticleIssue Date2019CitationBlood, v.134PublisherAmerican Society of Hematology
SCIESCOPUS
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studyopen access

Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Yoon, Dok Hyun; Yang, Deok-Hwan; Lee, Won Sik; Kim, Hyo Jung; Yhim, Ho-Young; Jeong, Seong Hyun, et al.

ArticleIssue Date2019CitationCANCER COMMUNICATIONS, v.39, no.1PublisherBMC
SCOPUSESCIKCI
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trialopen access

Seo, Jeongkuk; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Lee, Jae Hoon; Hong, Jun Shik; Lee, Gyeong-Won; Oh, Sung Yong; Lee, Ji-Hyun; Yoon, Dok Hyun, et al.

ArticleIssue Date2017CitationBLOOD RESEARCH, v.52, no.3, pp 200 - 206PublisherKOREAN SOC HEMATOLOGY
SCOPUSESCIKCI
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea

Ahn, Seo-Yeon; Son, Sang Kyun; Lee, Gyu Hyung; Kim, Inho; Cheong, June-Won; Lee, Won Sik; Kim, Byung Soo; Jo, Deog-Yeon; Jung, Chul Won; Seong, Chu Myoung, et al.

ArticleIssue Date2022CitationBlood Research, v.57, no.2, pp 144 - 151Publisher대한혈액학회
SCISCIESCOPUS
Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Lee, Suee; Lee, Dae Ho; Won, Jong-Ho; Hwang, In Gyu; Kim, Min Kyoung; Lee, Soon Il, et al.

ArticleIssue Date2010CitationCANCER SCIENCE, v.101, no.11, pp 2443 - 2447PublisherWILEY-BLACKWELL
SCISCIESCOPUS
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma

Lee, Gyeong-Won; Park, Sung Woo; Go, Se-Il; Kim, Hoon-Gu; Kim, Min Kyoung; Min, Chang-Ki; Kwak, Jae-Yong; Bae, Sang-Byung; Yoon, Sung-Soo; Lee, Je-Jung, et al.

ArticleIssue Date2018CitationACTA HAEMATOLOGICA, v.140, no.3, pp 146 - 156PublisherKARGER
SCIESCOPUS
The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores

Huh, SeokJae; Oh, Sung Yong; Lee, Suee; Lee, Ji Hyun; Kim, Sung Hyun; Lee, Gyeong-Won; Kim, Seok Jin; Kim, Won Seog; Lee, Ho Sup; Jo, Jae-Cheol, et al.

ArticleIssue Date2019CitationInternational Journal of Hematology, v.110, no.4, pp 438 - 446PublisherJapanese Society of Hematology
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어